Maximal potential patent foramen diameter does not correlate with the type or frequency of the neurologic event prior to closure

Cardiology

Volumn 113, Issue 2, 2009, Pages 111-115

  Kutty, Shelby ^a   Brown, Kimberly ^b   Qureshi, Athar M ^b   Latson, Larry A ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adult congenital heart disease; Patent foramen ovale; Pediatric cardiology; Stroke

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN INFARCTION; CATHETERIZATION; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; ANTICOAGULANTS; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; HYPERTENSION; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; STROKE; YOUNG ADULT;

EID: 56349137323     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000174290     Document Type: Article

References (21)

1. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A: Patent foramen ovale and cryp-togenic stroke in older patients. N Engl J Med 2007;357:2262-2268.
2. Kerut EK, Norfleet WT, Plotnick GD, Giles TD: Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623.
3. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
4. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP: Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesopha-geal echocardiographic study. Stroke 1994; 25:582-586.
5. Job FP, Ringelstein EB, Grafen Y, Flachskampf FA, Doherty C, Stockmanns A, Hanrath P: Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994;74:381-384.
6. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, Brainin M, Homma S, Sacco RL: Patent foramen ovale size and em-bolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
7. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P: Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 2002;33:293-296.
8. Kerr AJ, Buck T, Chia K, Chow CM, Fox E, Levine RA, Picard MH: Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantification. J Am Coll Cardiol 2000;36:1959-1966.
9. Schuchlenz HW, Weihs W, Horner S, Quehenberger F: The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000; 109:456-462; comment pp 506-507.
10. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR, Plotnick GD: Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131:158-161.
11. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG: Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
12. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; Investigators PFOiCSS: Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105:2625-2631.
13. Wahl A, Krumsdorf U, Meier B, Sievert H, Ostermayer S, Billinger K, Schwerzmann M, Becker U, Seiler C, Arnold M, Mattle HP, Windecker S: Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005;45:377-380.
14. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
15. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49:797-802.
16. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE: A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151:933-938.
17. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, Hinchey JA, Benesch C, Furie KL, Lutsep HL, Kelly E, Longstreth WT Jr: Increased pelvic vein thrombi in cryptogenic stroke: results of the paradoxical emboli from large veins in ischemic stroke (pelvis) study. Stroke 2004; 35: 46-50.
18. Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M: Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003;14:261-268.
19. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, Akkawi NM, Albertini A, Assanelli D, Vignolo LA, Padovani A: Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34:28-33.
20. Belvis R, Masjuan J, Garcia-Barragan N, Cocho D, Marti-Fabregas J, Santamaria A, Leta RG, Martinez-Castrillo JC, Fernandez-Ruiz LC, Gilo F, Marti-Vilalta JL: Stroke and pulmonary thromboembolism after a long flight. Eur J Neurol 2005; 12:732-734.
21. Hanisch F, Muller T, Krivokuca M, Winterholler M: Stroke following variceal sclero-therapy. Eur J Med Res 2004;9:282-284.